The kinetics of the tissue distribution of silver nanoparticles of different sizes

The kinetics of the tissue distribution of silver nanoparticles of different sizes

Abstract Blood kinetics and tissue distribution of 20, 80 and 110 nm silver nanoparticles were investigated in rats up to 16 days after intravenous administration once daily for 5 consecutive days. Following both single and repeated injection, silver nanoparticles disappeared rapidly from the blood...

Full description

Saved in:
Bibliographic Details
Published in:Biomaterials Vol. 31; no. 32; pp. 8350 - 8361
Main Authors: Lankveld, D.P.K, Oomen, A.G, Krystek, P, Neigh, A, Troost – de Jong, A, Noorlander, C.W, Van Eijkeren, J.C.H, Geertsma, R.E, De Jong, W.H
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 01-11-2010
Subjects:
Advanced Basic Science
Animals
Dentistry
Injections, Intravenous
Kinetics
Male
Models, Biological
Nanoparticles
Nanoparticles - administration & dosage
Nanoparticles - chemistry
Particle Size
Rats
Rats, Wistar
Silver
Silver - administration & dosage
Silver - blood
Silver - chemistry
Silver - pharmacokinetics
Tissue Distribution
Nanoparticles
Silver
Tissue distribution
Kinetics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Blood kinetics and tissue distribution of 20, 80 and 110 nm silver nanoparticles were investigated in rats up to 16 days after intravenous administration once daily for 5 consecutive days. Following both single and repeated injection, silver nanoparticles disappeared rapidly from the blood and distributed to all organs evaluated (liver, lungs, spleen, brain, heart, kidneys and testes) regardless of size. The 20 nm particles distributed mainly to liver, followed by kidneys and spleen, whereas the larger particles distributed mainly to spleen followed by liver and lung. In the other organs evaluated, no major differences between the sizes were observed. Size-dependent tissue distribution suggests size-dependent toxicity and health risks. Repeated administration resulted in accumulation in liver, lung and spleen, indicating that these organs may be potential target organs for toxicity after repeated exposure. A physiologically based pharmacokinetic (PBPK) model for nanoparticles which describes the kinetics of silver nanoparticles was developed. Model parameter values were estimated by fitting to data. No clear relation between parameter values and corresponding particle diameters became apparent.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2010.07.045